Your browser doesn't support javascript.
loading
The small molecule chemical compound cinobufotalin attenuates resistance to DDP by inducing ENKUR expression to suppress MYH9-mediated c-Myc deubiquitination in lung adenocarcinoma.
Liu, Jia-Hao; Yang, Hui-Ling; Deng, Shu-Ting; Hu, Zhe; Chen, Wei-Feng; Yan, Wei-Wei; Hou, Ren-Tao; Li, Yong-Hao; Xian, Rui-Ting; Xie, Ying-Ying; Su, Yun; Wu, Li-Yang; Xu, Ping; Zhu, Zhi-Bo; Liu, Xiong; Deng, Yu-Ling; Wang, Yu-Bing; Liu, Zhen; Fang, Wei-Yi.
Afiliação
  • Liu JH; Cancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, 510515, China.
  • Yang HL; Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.
  • Deng ST; School of Pharmacy, Guangdong Medical University, Dongguan, 523808, China.
  • Hu Z; Cancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, 510515, China.
  • Chen WF; Cancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, 510515, China.
  • Yan WW; Cancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, 510515, China.
  • Hou RT; Cancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, 510515, China.
  • Li YH; Cancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, 510515, China.
  • Xian RT; Cancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, 510515, China.
  • Xie YY; Cancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, 510515, China.
  • Su Y; Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
  • Wu LY; Cancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, 510515, China.
  • Xu P; Key Laboratory of Protein Modification and Degradation, Basic School of Guangzhou Medical University, Guangzhou, 511436, China.
  • Zhu ZB; Key Laboratory of Protein Modification and Degradation, Basic School of Guangzhou Medical University, Guangzhou, 511436, China.
  • Liu X; Respiratory Department, Peking University Shenzhen Hospital, Shenzhen, 518034, China.
  • Deng YL; Cancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, 510515, China.
  • Wang YB; Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
  • Liu Z; Department of Chinese Medicine Rehabilitation, Pingxiang People's Hospital, Pingxiang, 337055, China.
  • Fang WY; Cancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, 510515, China. wangyubing95117@163.com.
Acta Pharmacol Sin ; 43(10): 2687-2695, 2022 Oct.
Article em En | MEDLINE | ID: mdl-35296779
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Nasofaríngeas / Cisplatino / Adenocarcinoma de Pulmão / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Nasofaríngeas / Cisplatino / Adenocarcinoma de Pulmão / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article